Astrocyte-and endothelial-targeted CCL2 conditional knockout mice: Critical tools for studying the pathogenesis of neuroinflammation

Journal of Molecular Neuroscience

Volumn 39, Issue 1-2, 2009, Pages 269-283

  Ge, Shujun ^a   Murugesan, Nivetha ^a   Pachter, Joel S ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Astrocytes; Blood brain barrier; CCL2; Cell conditional knockout; Endothelial cells; Neuroinflammation

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; GENETIC RECOMBINATION; INFLAMMATION; KNOCKOUT MOUSE; LOXP SITE; MOUSE; NEUROINFLAMMATION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE;

ANIMALS; ASTROCYTES; CENTRAL NERVOUS SYSTEM; CHEMOKINE CCL2; E-SELECTIN; ENDOTHELIAL CELLS; GENOTYPE; INFLAMMATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; P-SELECTIN;

MUS; MUS MUSCULUS;

EID: 74149093963     PISSN: 08958696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12031-009-9197-4     Document Type: Article

References (95)

1. Abbott, N. J. (2000). Inflammatory mediators and modulation of blood-brain barrier permeability. Cellular and Molecular Neurobiology, 20, 131-147.
2. Abbott, N. J. (2006). Astrocyte-endothelial interactions at the blood-brain barrier. Nature Reviews. Neuroscience, 7, 41-53.
3. Adamus, G., Machnicki, M., Amundson, D., Adlard, K., & Offner, H. (1997). Similar pattern of CCL2 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis. Journal of Neuroscience Research, 50, 531-538.
4. Andjelkovic, A. V., & Pachter, J. S. (2000). Characterization of MCP-1 and MIP-1α binding sites along human brain microvessels. Journal of Neurochemistry, 75, 1898-1906.
5. Andjelkovic, A. V., Song, L., Dzenko, K. A., Cong, H., & Pachter, J. S. (2002). Functional expression of CCR2 by human fetal astrocytes. Journal of Neuroscience Research, 70, 219-231.
6. Anghelina, M., Moldovan, L., & Moldovan, N. I. (2005). Preferential activity of Tie2 promoter in arteriolar endothelium. Journal of Cellular and Molecular Medicine, 9, 113-121.
7. Babcock, A. A., Kuziel, W. A., Rivest, S., & Owens, T. (2003). Chemokine expression by glial cells directs leukocytes to sites of axonal injury. Journal of Neuroscience, 23, 7922-7930.
8. Bachoo, R. M., Kim, R. S., Ligon, K. L., Maher, E. A., Brennan, C., Billings, N., et al. (2004). Molecular diversity of astrocytes with implications for neurological diseases. Proceedings of the National Academy of Sciences of the United States of America, 101, 8384-8389.
9. Bechmann, I., Galea, I., & Perry, V. H. (2007). What is the blood-brain barrier (not) Trends in Immunology, 28, 5-11.
10. Bennett, J. L., Elhofy, A., Canto, M. C., Tani, M., Ransohoff, R. M., & Karpus, W. J. (2003). CCL2 transgene expression in the central nervous system directs diffuse infiltration of CD45 (hi) CD11b (+) monocytes and enhanced Theiler's murine encephalomyelitis virusinduced demyelinating disease. Journal of Neurovirology, 9, 623-636.
11. Berman, J. W., Guida, M. P., Warren, J., Amat, J., & Brosnan, C. F. (1996). Localization of monocyte chemoattractant protein-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat. Journal of Immunology, 156, 3017-3023.
12. Carpentier, P. A., Begolka, W. S., Olson, J. E., Elhofy, A., Karpus, W. J., & Miller, S. D. (2005). Differential activation of astrocytes by innate and adaptive immune stimuli. Glia, 49, 36-374.
13. Celie, J. W. A. M., Rutjkes, N. W. P., Keuning, E. D., Soininen, R., Heljasvaara, R., Pihlajaniemi, T., et al. (2007). Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion. American Journal of Pathology, 170, 1865-1878.
14. Choi, Y. K., & Kim, K.-W. (2008). Blood-neural barrier: its diversity and coordinated cell-to-cell communication. BMB Reports, 41, 345-352.
15. Crane, I. J., Wallace, C. A., McKillop-Smith, S., & Forrester, J. V. (2000). Control of chemokine production at the blood-brain barrier. Immunology, 101, 426-433.
16. Dawson, J., Miltz, W., Mir, A. K., & Wiessner, C. (2003). Targeting monocyte chemoattractant protein-1 signaling in disease. Expert Opinion on Therapeutic Targets, 7, 35-48.
17. dos Santos, A. C., Barsante, M. M., Arantes, R. M. E., Bernard, C. C. A., Teixeira, M. M., & Carvalho-Tavares, J. (2005). CCL2 and CCL5 mediate leukocyte adhesion in experimental autoimmune encephalomyelitis-an intravital microscopy study. Journal of Neuroimmunology, 162, 122-129.
18. Elhofy, A., Wang, J., Tani, M., Fife, B. T., Kennedy, K. J., Bennet, J., et al. (2005). Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis. Journal of Leukocyte Biology, 77, 229-237.
19. Fuentes, M. E., Durham, S. K., Swerdel, M. R., Lewin, A. C., Barton, D. S., Megill, J. R., et al. (1995). Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. Journal of Immunology, 155, 5769-5776.
20. Fujioka, T., Purev, E., & Rostami, A. (1999). Chemokine mRNA expression in the cauda equina of Lewis rats with experimental allergic neuritis. Journal of Neuroimmunology, 97, 51-59.
21. Ge, S., & Pachter, J. S. (2004). Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine MCP-1 by human astrocytes. Journal of Biological Chemistry, 279, 6688-6695.
22. Ge, S., Song, L., & Pachter, J. S. (2005). Where is the blood-brain barrier⋯really? Journal of Neuroscience Research, 79, 421-427.
23. Ge, S., Song, L., Serwanski, D., Kuziel, W. A., & Pachter, J. S. (2008). Transcellular transport of CCL2 across brain microvascular endothelial cells. Journal of Neurochemistry, 104, 1219-1232.
24. Gerszten, R. E., Garcia-Zapeda, E. A., Lim, Y.-C., Yoshida, M., Ding, H., Gimbrone, M. A., et al. (1999). MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature, 398, 718-723.
25. Glabinski, A. R., Tani, M., Tuohy, V. K., Tuthill, R. J., & Ransohoff, R. M. (1995). Central nervous system chemokine mRNA accumulation follows initial leukocyte entry at the onset of acute murine experimental autoimmune encephalomyelitis. Brain, Behavior, and Immunity, 9, 315-330.
26. Glabinski, A. R., Balasingam, V., Tani, M., Kunkel, S. L., Streiter, R. M., Yong, V. W., et al. (1996). Chemokine monocyte chemoattractant protein-1 is expressed by astrocytes after mechanical injury the brain. Journal of Immunology, 156, 4363-4368.
27. Hamann, I., Zipp, F., & Infante-Duarte, C. (2008). Therapeutic targeting of chemokine signaling in multiple sclerosis. Journal of the Neurological Sciences. doi:10.1016/j.jns.2008.07.005.
28. Hamby, M. E., Uliasz, T. F., Hewett, S. J., & Hewett, J. A. (2004). Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. Journal of Neuroscience Methods, 150, 128-137.
29. Handel, T. M., Johnson, Z., Rodrigues, D. H., dos Santos, A. C., Cirillo, R., Muzio, V., et al. (2008). An engineered monomer of CCL2 has anti-inflammatory properties emphasizing the importance of oligomerization for chemokine activity in vivo. Journal of Leukocyte Biology, 84, 1101-1108.
30. Harkness, K. A., Sussman, J. D., Davies-Jones, G. A., Greenwood, J., & Woodroofe, M. N. (2003). Cytokine regulation of MCP-1 expression in brain and retinal microvascular endothelial cells. Journal of Neuroimmunology, 142, 1-9.
31. Hayashi, M., Luo, Y., Laning, J., Streiter, R. M., & Dorf, M. E. (1995). Production and function of monocyte chemoattractant protein and other beta-chemokines in murine glial cells. Journal of Neuroimmunology, 60, 143-150.
32. Heesen, M., Tanabe, S., Berman, M. A., Yoshizawa, I., Luo, Y., Kim, R. J., et al. (1996). Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. Journal of Neuroscience Research, 45, 382-391.
33. Huang, D., Wang, J., Kivisakk, P., Rollins, B. J., & Ransohoff, R. M. (2001). Absence of monocyte chemoattractant protein-1 in mice leads to decreased local macrophage recruitment and antigenspecific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis. Journal of Experimental Medicine, 193, 713-725.
34. Huang, D., Tani, M., Wang, J., Han, Y. T. T., Weaver, J., Charo, I. F., et al. (2002). Pertussis toxin-induced reversible encephalopathy dependent on monocyte chemoattractant protein-1 overexpression in mice. Journal of Neuroscience, 22, 10633-10642.
35. Huang, D., Wujek, J., Kidd, G., He, T. T., Cardona, A., Sasse, M. E., et al. (2005). Chronic expression of monocyte chemoattractant protein-1 in the central nervous system causes delayed encephalopathy and impaired microglial function in mice. FASEB Journal, 19, 761-772.
36. Hughes, P. M., Alegrini, P. R., Rudin, M., Perry, V. H., Mir, A. K., & Wiessner, C. (2002). Monocyte chemoattractant protein-1 deficiency is protective in a murine stroke model. Journal of Cerebral Blood Flow and Metabolism, 22, 308-317.
37. Hulkower, K., Brosnan, C. F., Acquino, D. A., Cammer, W., Kulshrestha, S., Guida, M. P., et al. (1993). Expression of CSF-1, c-fms, and MCP-1 in the central nervous system of rats with experimental allergic encephalomyelitis. Journal of Immunology, 150, 2525-2533.
38. Infante-Duarte, C., Waiczies, S., Weurfel, J., & Zipp, F. (2008). New developments in understanding and treating neuroinflammation. Journal of Molecular Medicine, 86, 975-985.
39. Jovanova-Nesic, K., & Shoenfeld, Y. (2007). Autoimmunity in the brain: the pathogenesis insight from cell biology. Annals of the New York Academy of Sciences, 1107, 142-154.
40. Kalinowska, A., & Losy, J. (2008). Investigational C-C chemokine receptor 2 antagonists for the treatment of autoimmune diseases. Expert Opinion on Investigational Drugs, 17, 1267-1279.
41. Karpus, W. B., Fife, B. T., & Kennedy, K. J. (2003). Immunoneutralization of chemokines for the prevention and treatment of central nervous system autoimmune disease. Methods, 29, 362-368.
42. Kim, K. S. (1996). Cytokines and adhesion molecules in stroke and related diseases. Journal of Neurological Sciences, 137, 69-78.
43. Kinnecom, K., and Pachter, J. S. (2005). Selective capture of endothelial and perivascular cells from brain microvessels using laser capture microdissection. Brain Research Protocols, 16, 1-9.
44. Kipp, M., Norkute, A., Johann, S., Lorenz, L., Braun, S., Hieble, A., et al. (2008). Brain-region-specific astroglial responses in vitro after LPS exposure. Journal of Molecular Neuroscience, 35, 235-243.
45. Koni, P. A., Joshi, S. K., Temann, U. A., Olson, D., Burkly, L., & Flavell, R. A. (2001). Conditional vascular cell adhesion molecule-1 deletion in mice: impaired lymphocyte migration to bone marrow. Journal of Experimental Medicine, 193, 741-754.
46. Krasnowska-Zoladek, A., Banaszewska, M., Kraszpulski, M., & Konat, G. W. (2007). Kinetics of inflammatory response of astrocytes induced by TLR3 and TLR4 ligation. Journal of Neuroscience Research, 85, 205-212.
47. Kunkel, S. L., Standiford, T., Kasahara, K., & Streiter, R. M. (1991). Stimulus specific induction of monocyte chemoattractant protein-1 (MCP-1) gene expression. Advances in Experimental Medicine and Biology, 305, 65-71.
48. Larhtz, F., Piali, L., Spanaus, K. S., Seebach, J., & Fontana, A. (1998). Chemokines and chemotaxis of leukocytes in infectious meningitis. Journal of Neuroimmunology, 85, 33-43.
49. Lau, E. K., Paavola, C. D., Johnson, Z., Gaudry, J.-P., Geretti, E., Borlat, F., et al. (2004). Identification of the glycosaminoglycan binding site of the CC chemokine, CCL2: implications for structure and function in vivo. Journal of Biological Chemistry, 279, 22294-222305.
50. Lee, Y., Su, M., Messing, A., & Brenner, M. (2006). Astrocyte heterogeneity revealed by expression of a FAFP-LacZ transgene. Glia, 53, 677-687.
51. Leonard, E., & Yoshimura, T. (1990). Human monocyte chemoattractant protein-1 (MCP-1). Immunology Today, 11, 97-101.
52. Macdonald, J. A., Murugesan, N., and Pachter, J. S. (2008). Validation of immuno-laser capture microdissection coupled with quantitative RT-PCR to probe blood-brain barrier gene expression in situ. Journal of Neuroscience Methods, 174, 219-226.
53. McManus, C., Berman, J. W., Brett, F. M., Staunton, H., Farrell, M., & Brosnan, C. F. (1998). CCL2, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. Journal of Neuroimmunology, 86, 20-29.
54. Menetski, J., Mistry, S., Lu, M., Mudgett, J. S., Ransohoff, R. M., Demartino, J. A., et al. (2007). Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display nocioceptive responses. Neuroscience, 149, 706-714.
55. Ohtsuki, S., Kamiya, N., Hori, S., & Terasaki, T. (2005). Vascular endothelium-selective gene induction by Tie2 promoter/enhancer in the brain and retina of a transgenic rat. Pharmaceutical Research, 22, 852-857.
56. Omari, K. M., Chui, R., & Dorivini-Zis, K. (2004). Induction of betachemokine secretion by human brain microvessel endothelial cells via CD40/CD40L interactions. Journal of Neuroimmunology, 146, 203-208.
57. Pachter, J. S., de Vries, H. E., & Fabry, Z. (2003). The blood-brain barrier and its role in immune privilege in the central nervous system. Journal of Neuropathology and Experimental Neurology, 62, 593-604.
58. Pardridge, W. M. (2005). The blood-brain barrier and neurotherapeutics. NeuroRx, 2, 1-2.
59. Peterson, K. E., Erret, J. S., Wei, T., Dimcheff, D. E., Ransohoff, R., Kuziel, W. A., et al. (2004). MCP-1 and CCR2 contribute to nonlymphocyte- mediated brain disease induced by Fr98 polytropic retrovirus infection in mice: role for astrocytes in retroviral neuropathogenesis. Journal of Virology, 78, 6449-6458.
60. Piccio, L., Rossi, B., Scarpini, E., Laudanna, C., Ciagulli, C., Issekutz, A. C., et al. (2002). Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric Gilinked receptors. Journal of Immunology, 168, 1940-1949.
61. Prat, A., Biernacki, K., Wosik, K., & Antel, J. P. (2001). Glial cell influence on the human blood-brain barrier. Glia, 36, 145-155.
62. Prat, A., Biernacki, K., Lavoie, J. F., Poirier, J., Duquette, P., & Antel, J. P. (2002). Migration of multiple sclerosis lymphocytes through brain endothelium. Archives of Neurology, 59, 391-397.
63. Prieschl, E. E., Kulmburg, P. A., & Baumrucker, T. (1995). The nomenclature of chemokines. International Archives of Allergy and Immunology, 107, 475-483.
64. Qin, H., He, J., Hanes, R. N., Pluzarev, O., Hong, J. S., & Crews, F. T. (2008). Increased systemic and brain cytokine production and neuroinflammation by endotoxin following ethanol treatment. Journal of Neuroinflammation, 5, 10-26.
65. Quandt, J., & Dorovini-Zis, K. (2004). The beta chemokines CCL4 and CCL5 enhance adhesion of specific CD4 + T cell subsets to human brain endothelial cells. Journal of Neuropathology and Experimental Neurology, 63, 350-362.
66. Rankine, E. L., Hughes, P. M., Botham, M. S., Perry, V. H., & Felton, L. M. (2006). Brain cytokine synthesis induced by an intraparenchymal injection of LPS is reduced in MCP-1-deficient mice prior to leukocyte recruitment. European Journal of Neuroscience, 24, 77-86.
67. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., et al. (1993). Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB Journal, 7, 592-600.
68. Rollins, B. J. (1991). JE/MCP-1: an early-response gene encodes a monocyte-specific response. Cancer Cells, 3, 517-524.
69. Rollins, B. J., Walz, A., & Baggiolini, M. (1991). Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood, 78, 1112-1116.
70. Sakurai-Yamashita, Y., Shigematsu, K., Yamashita, K., & Niwa, M. (2006). Expression of MCP-1 in the hippocampus of SHRSP with ischemia-related delayed neuronal death. Cellular and Molecular Neurobiology, 26, 823-831.
71. Schober, A. (2008). Chemokines in vascular dysfunction and remodeling. Arteriosclerosis, Thrombosis and Vascular Biology, 28, 1950-1959.
72. Sequin, R., Biernacki, K., Rotondo, R. L., Prat, A., & Antel, J. P. (2003). Regulation and functional effects of monocyte migration across human brain-derived endothelial cells. Journal of Neuropathology and Experimental Neurology, 62, 412-419.
73. Simpson, J. E., Newcombe, J., Cuzner, M. L., & Woodruffe, M. N. (1998). Expression of monocyte chemoattractant protein and other beta chemokines by resident glia and inflammatory cells in multiple sclerosis lesions. Journal of Neuroimmunology, 84, 238-249.
74. Singh, A. K., & Jiang, Y. (2004). How does peripheral lipopolysaccharide induce gene expression in the brain of rats? Toxicology, 201, 197-207.
75. Sixt, M., Engelhardt, B., Pausch, F., Hallman, R., Wendler, O., & Sorokin, L. M. (2001). Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalitis. Journal of Cell Biology, 153, 933-945.
76. So, E. Y., Kang, M. H., & Kim, B. S. (2006). Induction of chemokine and cytokine genes in astrocytes following infection with Theiler's murine encephalomyelitis virus is mediated by the Toll-like receptor 3. Glia, 53, 858-867.
77. Song, L., & Pachter, J. S. (2003). Culture of murine brain microvascular endothelial cells that maintain expression and cytoskeletal association of tight junction-associated proteins. In Vitro Cellular and Developmental Biology. Animal, 39, 313-320.
78. Song, L., & Pachter, J. S. (2004). Monocyte chemoattractant protein-1 alters expression of tight junction-associated proteins in brain microvascular endothelial cells. Microvascular Research, 67, 78-89.
79. Song, L., Ge, S., & Pachter, J. S. (2007). Caveolin-1 regulates expression of junction-associated proteins in microvascular endothelial cells. Blood, 109, 1515-1523.
80. Sun, J., Zheng, J. H., Zhao, M., Lee, S., & Goldstein, H. (2008). Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R54 human immunodeficiency type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysaccharides. Journal of Virology, 82, 5562-5572.
81. Thibeault, I., Laflamme, N., & Rivest, S. (2001). Regulation of the gene encoding the monocyte chemoattractant protein 1 (MCP-1) in the mouse and rat brain in response to LPS and proinflammatory cytokines. Journal of Comparative Neurology, 434, 461-477.
82. Thompson, W. L., Karpus, W. J., & Van Eldik, L. J. (2008). MCP-1-deficient mice show reduced neuroinflammatory responses and increased peripheral inflammatory responses to peripheral endotoxin insult. Journal of Neuroinflammation, 5, 35-48.
83. Thurston, G., Baluk, P., & McDonald, D. M. (2000). Determinants of endothelial cell phenotype in venules. Microcirculation, 7, 67-80.
84. Toborek, M., Lee, Y. W., Pu, H., Malecki, A., Flora, G., Garrido, R., et al. (2003). HIV-Tat protein induces oxidative and inflammatory pathways in brain endothelium. Journal of Neurochemistry, 84, 169-179.
85. Van der Voorn, P., Tekstra, J., Beelen, R. H., Tensen, C. P., Van, D. V., & De, G. C. (1999). Expression of CCL2 by reactive astrocytes in demyelinating multiple sclerosis lesions. American Journal of Pathology, 154, 45-51.
86. van Horssen, J., Bo, L., Vos, C. M. P., Virtanen, I., & de Vries, H. E. (2005). Basement membrane proteins in multiple sclerosisassociated inflammatory cuffs: potential role in influx and transport of leukocytes. Journal of Neuropathology and Experimental Neurology, 64, 722-729.
87. Wang, X., & Feuerstein, G. Z. (1995). Induced expression of adhesion molecules following focal brain ischemia. Journal of Neurotrauma, 12, 825-832.
88. Xaio, H., Banks, W. A., Niehoff, M. L., & Morley, J. E. (2001). Effect of LPS on the permeability of the blood-brain barrier to insulin. Brain Research, 896, 36-42.
89. Yamamoto, M., Horiba, M., Buescher, J. L., Huang, D., Gendelman, H. E., Ransohoff, R. M., et al. (2005). Overexpression of monocyte chemoattractant protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse amyloid deposition. American Journal of Pathology, 166, 1475-1485.
90. Yoshimura, T., Takeya, M., Takahashi, K., Kuratsu, J., & Leonard, E. J. (1991). Production and characterization of mouse monoclonal antibodies against human monocyte chemoattractant protein-1. Journal of Immunology, 147, 2229-2233.
91. Zernecke, A., & Weber, C. (2005). Inflammatory mediators in atherosclerotic vascular disease. Basic Research in Cardiology, 100, 93-101.
92. Zhang, W., Smith, C., Howlett, C., & Stanimirovic, D. (2000). Inflammatory activation of human brain endothelial cells by hypoxic astrocytes in vitro is mediated by IL-1beta. Journal of Cerebral Blood Flow and Metabolism, 20, 967-978.
93. Zhou, H., Lapointe, B. M., Clark, S. R., Zbytnuik, L., & Kubes, P. (2006). A requirement for microglial TLR4 in leukocyte recruitment into brain in response to lipopolysaccharide. Journal of Immunology, 177, 8103-8110.
94. Zhuo, L., Theis, M., Alvarez-Maya, I., Brenner, M., Willecke, K., & Messing, A. (2001). hGFAP-cre transgenic mice for manipulation of glial and neuronal function in vivo. Genesis, 31, 85-94.
95. Zuurman, M. W., Heeroma, J., Brouer, N., Boddeke, H. W., & Biber, K. (2003). LPS-induced expression of a novel chemokine receptor (L-CCR) in mouse glial cells in vitro and in vivo. Glia, 41, 327-336.